Results 81 to 90 of about 2,248 (160)

Decoding Bromodomain and Extra-Terminal Domain Protein-Mediated Epigenetic Mechanisms in Human Uterine Fibroids. [PDF]

Int J Mol Sci
Yang Q, Vafaei S, Falahati A, Khosh A, Omran MM, Bai T, Bariani MV, Ali M, Boyer TG, Al-Hendy A.   +9 more
europepmc   +1 more source

Fadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression. [PDF]

Cell Commun Signal
Kim JM, Nam AR, Oh KS, Bang JH, Jeong Y, Choo SY, Kim HJ, Lee SI, Yoon J, Kim TY, Oh DY.   +10 more
europepmc   +1 more source

The influence of bapineuzumab and semagacestat on rapid progressors: A retrospective cohort study. [PDF]

J Prev Alzheimers Dis
Harris K, Shyer M, Wang D, He E, Cattani M, Zhang C, Farrell CM, Jiang X, Kim Y, Schulz PE.   +9 more
europepmc   +1 more source

Berzosertib enhances the sensitivity of pediatric diffuse midline glioma H3K27-altered cells to radiotherapy. [PDF]

Cell Death Dis
Gorainow N, Sander F, Picard D, Frölich MC, Eul K, Etemadi Afshar S, Asche J, Monje M, Raabe E, Bartl J, Borkhardt A, Reifenberger G, Dünker N, Busch M, Pauck D, Qin N, Matschke J, Remke M, Jendrossek V.   +18 more
europepmc   +1 more source

The Effect of Serotonin 5-HT_2C Receptor Modulation on Binge Drinking and Alcohol-Seeking in Female Mice. [PDF]

Addict Biol
Anversa RG, Tran L, Bolinger AA, Zhou J, Cunningham KA, Lawrence AJ, Campbell EJ.   +6 more
europepmc   +1 more source

Cerebral Inhibition of the H3K9 Methylation Could Ameliorate Blood-Brain Barrier Dysfunction and Neural Damage in Vascular Dementia. [PDF]

Arch Razi Inst
Sehati F, Ranjbaran M, Nabavizadeh F, Karimian SM, Hosseindoost S, Ashabi G.   +5 more
europepmc   +1 more source

Hypoxia-activated paclitaxel prodrugs enable PD-L1 degradation to potentiate cancer chemo-immunotherapy. [PDF]

J Nanobiotechnology
Zhou S, Zhang Q, Han H, Chen G, Wang P, Xue S, Pei Q, Xie Z, Meng X.   +8 more
europepmc   +1 more source

Pleiotropic effects of BET inhibition broadly boost tumor immunogenicity to CD8^<b>+</b> T cells. [PDF]

Oncoimmunology
Melief J, Baldran-Groves L, Gerault MA, Liang YY, Pasca S, de Los Santos MC, Wickström S, Lövgren T, Ramos AD, Larsson LG, Nordlund P, Seliger B, Kiessling R.   +12 more
europepmc   +1 more source